Here's why Eternal shares can rise up to 75% from current levels despite competition as per analysts

Here’s why Eternal shares can rise up to 75% from current levels despite competition as per analysts

Shares of Eternal are fluctuating between gains and losses on Thursday, July 23, a day after the company’s June-quarter results, which were a mixed bag. However, the results prompted brokerages to reiterate their bullish stance, with CLSA seeing nearly 75% upside on the stock following strong growth in both food delivery and quick commerce. Eternal…

Read More
Nestle India Share Price: Growth Vs Valuation debate splits street down the middle

Nestle India Share Price: Growth Vs Valuation debate splits street down the middle

Shares of Nestle India fell more than 2% on Thursday, July 23, after the fast-moving consumer goods (FMCG) major reported another quarter of better-than-expected earnings for the June quarter. However, despite the strong earnings performance, the growth vs valuation debate has split the 40 analysts who track the company right down the middle. Citi sees…

Read More
Zydus receives USFDA approval to begin Phase III trial of sickle cell anaemia treatement drug with ICMR

Zydus receives USFDA approval to begin Phase III trial of sickle cell anaemia treatement drug with ICMR

Zydus Lifesciences on Thursday, July 23, said it has received approval to begin a Phase III clinical trial of its investigational drug Desidustat for treating anaemia in patients with sickle cell disease (SCD), in collaboration with the Indian Council of Medical Research (ICMR). The 203-day, double-blind, randomised, placebo-controlled, parallel, multicentre study will enrol 164 patients…

Read More